Document is current

Any future updates will be listed below

148 PBRM1 mutation improves immunotherapy response in clear-cell renal cell carcinoma patients contingent on metabolic subtypes

Crossref DOI link: https://doi.org/10.1136/jitc-2024-SITC2024.0148

Published Online: 2024-11-05

Published Print: 2024-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark